BioSpace News Archive

Biotech Beach

Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-based Virotherapy (SuperNova) Platform Technology at SITC 2023

Calidi Biotherapeutics, Inc. today announced a poster highlighting new preclinical data and clinical development plans from the company’s novel SuperNova technology will be presented at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting in San Diego, CA, taking place November 1-5, 2023.

October 10, 2023
·
2 min read
Business

Foundation Medicine and Natera Announce Broad Clinical Launch and Medicare Coverage of FoundationOne®Tracker

FoundationOne ® Tracker is now available to all physicians in the United States seeking personalized monitoring of their patients’ response to treatment.

October 10, 2023
·
6 min read
Drug Development

AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations

AVB-101 is an investigational gene therapy designed to halt disease progression by delivering a functional copy of the GRN gene to restore appropriate progranulin levels in the brain.

October 10, 2023
·
5 min read
Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction

Results Demonstrate the Active Pharmaceutical Ingredient in Cardiol’s Novel CRD-38 Formulation Attenuates Harmful Fat Distribution and Key Markers of Cardiac Inflammation and Remodelling

October 10, 2023
·
8 min read
ETAP-Lab announces the acquisition of SYNCROSOME

MARSEILLES, 10th October 2023 - ETAP-Lab, a preclinical contract research organisation (CRO) specialising in neurology and dermatology, announces the acquisition of SYNCROSOME (PACA)

October 10, 2023
·
3 min read
Business

MilliporeSigma Partner Beyond Benign Launches New Green Chemistry Teaching and Learning Community Online Platform

Global green chemistry education nonprofit Beyond Benign has launched its Green Chemistry Teaching and Learning Community free online platform to help the green chemistry community around the world connect and learn together.

October 10, 2023
·
2 min read
Business

Median Technologies Appoints Ben McDonald to its Board of Directors

Median Technologies (Paris:ALMDT) announced today that Ben McDonald has joined its Board of Directors, chaired by Oran Muduroglu.

October 10, 2023
·
3 min read
PharmEnable Therapeutics and Sosei Heptares Expand Drug Discovery Collaboration

PharmEnable Therapeutics, a UK drug discovery company, and Sosei Heptares (TSE: 4565), the international biopharmaceutical company

October 10, 2023
·
5 min read
Health Canada Grants BioHarvest Sciences License for VINIA Sales in Canada

BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that VINIA®, its flagship nutraceutical product derived from red grape cells, has received its Canadian product license from Health Canada’s Natural and Non-Prescription Health Products Directorate

October 10, 2023
·
5 min read
Deals

Mallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial Restructuring Plan

Mallinckrodt plc, a global specialty pharmaceutical company, announced that its Plan of Reorganization has been confirmed by the U.S. Bankruptcy Court for the District of Delaware, positioning the Company to emerge from Chapter 11 by the end of the year.

October 10, 2023
·
8 min read